OLMA · Olema Oncology, Inc. · Executive Compensation
$7.02
-0.13 (-1.82%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2024 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, these conditions raise substantial doubt about our ability to continue as a going concern over the long term.”View the 10-Q filed Nov 10, 2026
Market Cap
$615.00M
Shares
87.61M
Volume · Nov 20
1.26M
Avg daily vol (3M)
1.27M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Prakash Raman | Compensation Committee of the Board | Appointed | 2026-10-15 |
|
Dr. Gorjan Hrustanovic
“Dr. Hrustanovic’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
|
Board of Directors | Resigned | 2026-10-15 |
| Jason O'Byrne | Chief Financial Officer | Appointed | 2026-08-13 |
| Jason O'Byrne | principal accounting officer | Appointed | 2026-08-13 |
| Jason O'Byrne | Chief Financial Officer | Appointed | 2026-08-13 |
| Dr. Prakash Raman | Class II director | Appointed | 2026-04-29 |
| Yi Larson | Class III director | Appointed | 2021-04-06 |
|
Frank McCormick
“Dr. McCormick’s resignation was not the result of any disagreement or dispute with the Company.”
|
a director of Olema Pharmaceuticals, Inc. | Resigned | 2021-04-06 |
Leadership
- Sean Bohen CEO, Board Member
- Jason O'Byrne CFO, Chief Accounting Officer
- Dr. Prakash Raman Board Member
- Prakash Raman Board Member
- Yi Larson Board Member
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
188 filings
170 filers
Visit website
Investor relations